Research Article
Anticancer and Antimicrobial Activity of Some New 2,3-Dihydro-1,5-benzodiazepine Derivatives
Table 3
Crystallographic data and structure refinement summary for compounds 9.
| Property | Compound 9 |
| Formula | C19H20N2O, CH4O | CCDC | 2141381 | Formula weight | 324.41 | Crystal system | Monoclinic | Space group | P21/c | a (Ǻ) | 12.4123 (7) | b (Ǻ) | 7.3789 (3) | c (Ǻ) | 19.6257 (11) | α (°) | 90 | β (°) | 98.609 (2) | γ (°) | 90 | V (Å3) | 1777.25 (16) | Z | 4 | ρ (g/cm3) | 1.212 | µ (mm−1) | 0.079 | F (000) | 696 | Crystal size (mm) | 0.43 × 0.50 × 0.50 | Temperature (K) | 296 | MoKa radiation (Ǻ) | 0.71073 | Theta min-max (°) | 1.7, 28.3 | Dataset | −16 : 15; −8 : 9; −22 : 26 | Tot., uniq. data, R (int) | 31222, 4349, 0.031 | Observed data (I > 2.0 sigma (I)) | 3532 | Nref | 4349 | Npar | 226 | R | 0.0466 | wR2 | 0.13090 | S | 1.04 | Max. and av. shift/error | 0.00, 0.00 | Δρmin, Δρmax (e Å-3) | −0.33, 0.42 | Max. resd. dens. (e/Å3) | 0.42 |
|
|